Clinical Center; Notice of Meeting, 10541 [2014-04078]
Download as PDF
<![CDATA[
Federal Register / Vol. 79, No. 37 / Tuesday, February 25, 2014 / Notices
Dated: February 20, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
[FR Doc. 2014–04078 Filed 2–24–14; 8:45 am]
Clinical Center; Notice of Meeting
BILLING CODE 4140–01–P
emcdonald on DSK67QTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(9)(B), Title 5 U.S.C., as amended
because the premature disclosure of to
discuss personnel matters and the
discussions would likely to significantly
frustrate implementation of
recommendations.
Name of Committee: NIH Advisory Board
for Clinical Research.
Date: March 31, 2014.
Open: 10:00 a.m. to 1:00 p.m.
Agenda: To review the FY15 Clinical
Center Budget.
Place: National Institutes of Health,
Building 10, CRC Medical Board Room
4–2551, 10 Center Drive, Bethesda, MD
20892.
Closed: 1:10 p.m. to 2:00 p.m.
Agenda: To discuss personnel matters and/
or issues of which the premature discloser
may affect outcomes.
Place: National Institutes of Health,
Building 10, CRC Medical Board Room
4–2551, 10 Center Drive, Bethesda, MD
20892.
Contact Person: Maureen E. Gormley,
Executive Secretary, Mark O. Hatfield
Clinical Research Center, National Institutes
of Health, Building 10, Room 6–2551,
Bethesda, MD 20892, (301) 496–2897.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
VerDate Mar<15>2010
17:58 Feb 24, 2014
Jkt 232001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; P41 Imaging Review
(2014/10).
Date: May 30, 2014.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Ruth Grossman, DDS,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
6707 Democracy Boulevard, Room 960,
Bethesda, MD 20892, 301–496–8775,
grossmanrs@mail.nih.gov.
Dated: February 20, 2014.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–04080 Filed 2–24–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00076
Fmt 4703
Sfmt 4703
10541
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Biological Chemistry, Biophysics
and Drug Discovery.
Date: March 3, 2014.
Time: 8:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Sergei Ruvinov, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4158,
MSC 7806, Bethesda, MD 20892, 301–435–
1180, ruvinser@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflict: Oral, Dental and Craniofacial
Sciences.
Date: March 3, 2014.
Time: 2:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Jo Pelham, BA, Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4102, MSC 7814, Bethesda, MD
20892, (301) 435–1786, pelhamj@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel,
Fellowships: Cell Biology, Developmental
Biology, and Bioengineering.
Date: March 6, 2014.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Kenneth Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7717, Bethesda, MD 20892, 301–435–
1789, kenneth.ryan@nih.hhs.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\25FEN1.SGM
25FEN1
]]>Agencies
[Federal Register Volume 79, Number 37 (Tuesday, February 25, 2014)]
[Notices]
[Page 10541]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-04078]
[[Page 10541]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Clinical Center; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the NIH
Advisory Board for Clinical Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in section 552b(c)(9)(B), Title 5 U.S.C., as
amended because the premature disclosure of to discuss personnel
matters and the discussions would likely to significantly frustrate
implementation of recommendations.
Name of Committee: NIH Advisory Board for Clinical Research.
Date: March 31, 2014.
Open: 10:00 a.m. to 1:00 p.m.
Agenda: To review the FY15 Clinical Center Budget.
Place: National Institutes of Health, Building 10, CRC Medical
Board Room 4-2551, 10 Center Drive, Bethesda, MD 20892.
Closed: 1:10 p.m. to 2:00 p.m.
Agenda: To discuss personnel matters and/or issues of which the
premature discloser may affect outcomes.
Place: National Institutes of Health, Building 10, CRC Medical
Board Room 4-2551, 10 Center Drive, Bethesda, MD 20892.
Contact Person: Maureen E. Gormley, Executive Secretary, Mark O.
Hatfield Clinical Research Center, National Institutes of Health,
Building 10, Room 6-2551, Bethesda, MD 20892, (301) 496-2897.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Dated: February 20, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-04078 Filed 2-24-14; 8:45 am]
BILLING CODE 4140-01-P
